Poland· PL-100539844

Evastix

A ebastine product containing ebastinum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 13 of our 19 countries.

ATC R06AX22

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedEvastixATCR06AX22REGISTER NO.PL-100539844PACKS LISTED5CHECKEDSeptember 27, 2026

Where it is registered

Ebastine is registered in 13 of 19 countries.

Countries holding a registration under ATC R06AX22 (ebastine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Ebastine · ATC R06AX22

13 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ebastine costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.15 in France to $0.27 in Italy — a ×1.8 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ebastine · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • IT Italy$0.27
  • FR France$0.15
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Ebastinum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
R06AX22
ATC class
Ebastine
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    05909991603946
  • gtin
    05909991603953
  • gtin
    05909991603960
  • gtin
    05909991603977
  • gtin
    05909991603984

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ebastine in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ebastine products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Belgium · Ebastine Filmtabletten Teva, Ebastine Sandoz
  • Cyprus · Ebastel
  • Germany · Ebastel, Ebastin Aristo
  • Denmark · Ebastin "brown", Ebastin Brown
  • Estonia · Kestine
  • Spain · Bactil, Bactil Flas
  • Finland · Ebastin Orion, Kestine
  • France · Ebastine Arrow, Ebastine Arrow Lab
  • Greece · Kestine, Kestine Flash
  • Iceland · Kestine, Kestine Flash
  • Italy · Clever, Decastin
  • Lithuania · Kestine
  • Luxembourg · Estivan, Estivan Lyo
  • Latvia · Kestine
  • Netherlands · Ebastine Aurobindo, Ebastine Smelt Teva
  • Norway · Ebastin Orifarm, Kestine
  • Portugal · Ebastina Alter, Ebastina Generis
  • Sweden · Ebastin Abece, Ebastin Apofri

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/306f8361-9063-4ca0-a713-4d9f64729ec9
GET /v1/drugs/306f8361-9063-4ca0-a713-4d9f64729ec9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki ulegające rozpadowi w jamie ustnej",
  "source": "urpl",
  "strength": "10 mg",
  "packaging": "05909991603946 ¦ Rp ¦ 167463\n10 tabl.\n05909991603953 ¦ Rp ¦ 167464\n20 tabl.\n05909991603960 ¦ Rp ¦ 167465\n30 tabl.\n05909991603977 ¦ Rp ¦ 167466\n50 tabl.\n05909991603984 ¦ Rp ¦ 167467\n90 tabl.",
  "substance": "Ebastinum/10 mg",
  "common_name": "Ebastinum",
  "pl_product_id": "100539844",
  "pozwolenie_nr": "228/26",
  "auth_procedure": "IR",
  "authorisation_validity": "2031-06-15"
}

See everything about ebastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.